About the Editors
Editor-in-Chief
Janet Zoldan, PhD
Associate Professor of Biomedical Engineering
Austin, TX, USA
My research program at The University of Texas at Austin is focused on human induced pluripotent stem cells (iPSCs) as a model system to explore key principles underlying cardiovascular tissue formation processes. To control these processes, we design three dimensional (3D) matrixes with tunable physical, chemical, and biological properties, providing a range of control signals. Utilizing these tools, my research program is centered around two specific goals: (i) deciphering the role of physical cues in the complex process of iPSCs differentiation into cardiovascular lineages, and (ii) developing microenvironments favorable for cardiovascular tissue formation. These engineered environments provide a platform for fundamental research in tissue development, investigation of disease mechanisms, testing of drugs, and the development of solutions for in situ tissue regeneration.
Associate Editors
Seung-Woo Cho, PhD
Professor, Department of Biotechnology
Seoul,Republic of Korea
My research interests include engineering stem cells, reprogrammed cells, and organoids with functional biomaterials, nanomaterials, and microfluidic devices for tissue engineering, disease modeling, and drug screening.
Silviya Zustiak, PhD
Professor and Associate Chair, Department of Biomedical Engineering
St. Louis, MO, USA
Dr. Zustiak’s research is focused on hydrogel biomaterials for tissue engineering and drug delivery applications, with emphasis on developing novel biomaterials as localized drug delivery devices, cell scaffolds and drug screening platforms, and elucidating matrix structure-property relationships as well as cell-matrix interactions. Biomaterial-based models are crucial for bridging the gap between traditional tissue culture and animal models by providing a cell environment that closely mimics real tissue. This research is highly multidisciplinary, merging the fields of engineering, materials science, and biology.
Advisory Editor
Filipe Almeida, PhD
Springer Nature, Germany
Filipe studied the influence of the biomechanics of the tumor microenvironment at The Wistar Institute in Philadelphia, and most recently developed composite biomaterials for the delivery of anticancer drugs at NOVA University of Lisbon. Previously, at Queen Mary University of London, where he obtained his PhD in 2015, he studied how skin cells respond to their microenvironment by using advanced microfabricated biomaterials, and developed micropatterned surfaces for high-content drug screening. Filipe’s interests span mechanobiology, biomechanics, cellular imaging, tissue engineering, nanotheranostics and cancer therapies. Filipe joined Nature Biomedical Engineering in November 2021.
Interested in joining the journal team?
If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.
Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.
Please note that we are not able to respond to all applicants.
